Is LunaBill profitable in 2026?

No profitability figures have been disclosed. LunaBill reported $764K in contracted ARR, with $428K live, as of its YC page update on 2026-01-31. The company is seed-stage with a team of about 4-10 people and no reported net income.

Who is LunaBill's biggest competitor?

Candid Health and Infinitus Systems are LunaBill's closest rivals. Candid Health raised a $120M Series D on 2026-07-22 with 200+ enterprise customers and 190% YoY ARR growth, far outscaling LunaBill's small seed-funded team.

How much funding has LunaBill raised?

LunaBill raised a seed round of approximately $3.5M from Y Combinator and Pioneer Fund, reported as closing around 2025-11-18, per Preqin and CB Insights data. No valuation has been publicly disclosed.

Could AI replace LunaBill?

LunaBill's entire product is AI voice agents automating insurance calls, so it is itself an AI deployment rather than facing frontier-model replacement. Its bigger exposure is larger rivals like Infinitus, which launched an Agentic AI Member Services Suite on 2026-02-03, and Candid Health's platform-scale RCM push.

What does LunaBill actually do?

LunaBill builds AI voice agents that call U.S. insurance payers to check claim status, chase accounts-receivable, handle denials, and file appeals for hospital billing teams. It launched in July 2025 as part of YC's Fall 2025 batch and is based in San Francisco.

Has LunaBill changed its pricing model?

Yes. Preqin reported LunaBill using a subscription model as of 2025-11-17, but by 2026-06-30 the company's site described outcomes-based pricing of 1.5% of net collections recovered with no upfront fees, indicating a pivot within roughly seven months.

YC Fall 2025 · United States

Lunabill

lunabill.com ↗

AI voice agents that call insurers to chase down unpaid hospital claims.

Losing its protection

Assessed 27 July 2026 · Evidence as of 27 July 2026

The structural protection is eroding.

On the recordSince 27 July 2026 · Checkable from Q4 2026 to Q1 2027 · Every call on the record Checkpoint: Candid Health or Infinitus Systems launching a claim-follow-up-specific feature in Lunabill's exact sub-niche

The call

Lunabill sits in a real, proven niche but shares it with better-funded rivals moving fast, and its edge depends on locking in workflow depth before they do.

LunaBill calls hospital patients to collect unpaid medical bills using AI voice agents and charges based on results. Other companies like Candid Health and Infinitus Systems are already doing similar work, have more money, more customers, and are growing faster, so copying LunaBill's idea is straightforward for them. The key question is whether LunaBill can go deep enough in one specific task (following up on denied claims at hospitals) and lock in customers before its bigger rivals decide to compete in that exact spot.

Why

AI pressure: General-purpose AI voice-agent platforms (e.g. Retell AI, Bland AI, Vapi). Hospitals or RCM firms could assemble similar call-automation using generic agent platforms, eroding Lunabill's technical edge. Could AI do the core job? Only partly.

Bigger players: Candid Health and Infinitus Systems. Candid Health has 200+ enterprise customers and 190% YoY growth; Infinitus shipped an agentic payer-services suite in Feb 2026 covering similar ground. Could a giant copy it? Yes, easily.

What protects it. Deep workflow lock-in inside hospital A/R teams and outcomes-based pricing tied to actual claims recovered, if it holds before rivals move in.

What would change this call

Candid Health or Infinitus Systems launches a claim-follow-up/denial-handling voice agent by Q4 2026. Would show LunaBill's sub-niche window has closed and rivals are absorbing its target customers.
LunaBill produces an independently verified (non-company) customer case study within a year. Would show its traction claims hold up beyond self-reported figures.
LunaBill's employee count grows beyond its current 4-10 range with enterprise-deployment hires. Would show it can scale delivery to defend accounts against larger rivals.

Key numbers

$764K contracted ARR, $428K live revenue (2026-01-31)
60,000+ calls automated, $30M+ recovered (2025-11-11)
100% of pilots converted to paying customers (2025-11-11)

Named risks

Better-funded specialized peers (Candid Health, Infinitus) can replicate LunaBill's claim-follow-up niche with far greater capital. Severity: high
Traction figures (calls, revenue, case studies) are self-reported with no independent third-party verification found. Severity: medium
Very small team of roughly 4-10 people limits ability to scale enterprise deployments and complete SOC 2 Type II certification. Severity: medium
Recent pricing-model pivot from subscription to outcomes-based fees could create revenue volatility. Severity: medium
No structural moat identified beyond category-standard integrations and compliance, easily matched by rivals. Severity: high

Rivals, as read in July 2026

Rival	Direction	Evidence
Candid Health	gaining on	$120M Series D, 200+ enterprise customers, 190% YoY ARR growth as of 2026-07-22
Infinitus Systems	gaining on	Launched Agentic AI Member Services Suite on 2026-02-03; 4M+ automated calls since 2019
AKASA	contesting	Named as active AI-RCM peer in MedCity News coverage on 2026-07-26
RapidClaims	contesting	Named alongside Candid Health as AI-RCM peer, 2026-07-26
Nym Health	contesting	Named alongside Candid Health as AI-RCM peer, 2026-07-26

Questions people ask

Is LunaBill profitable in 2026?: No profitability figures have been disclosed. LunaBill reported $764K in contracted ARR, with $428K live, as of its YC page update on 2026-01-31. The company is seed-stage with a team of about 4-10 people and no reported net income.
Who is LunaBill's biggest competitor?: Candid Health and Infinitus Systems are LunaBill's closest rivals. Candid Health raised a $120M Series D on 2026-07-22 with 200+ enterprise customers and 190% YoY ARR growth, far outscaling LunaBill's small seed-funded team.
How much funding has LunaBill raised?: LunaBill raised a seed round of approximately $3.5M from Y Combinator and Pioneer Fund, reported as closing around 2025-11-18, per Preqin and CB Insights data. No valuation has been publicly disclosed.
Could AI replace LunaBill?: LunaBill's entire product is AI voice agents automating insurance calls, so it is itself an AI deployment rather than facing frontier-model replacement. Its bigger exposure is larger rivals like Infinitus, which launched an Agentic AI Member Services Suite on 2026-02-03, and Candid Health's platform-scale RCM push.
What does LunaBill actually do?: LunaBill builds AI voice agents that call U.S. insurance payers to check claim status, chase accounts-receivable, handle denials, and file appeals for hospital billing teams. It launched in July 2025 as part of YC's Fall 2025 batch and is based in San Francisco.
Has LunaBill changed its pricing model?: Yes. Preqin reported LunaBill using a subscription model as of 2025-11-17, but by 2026-06-30 the company's site described outcomes-based pricing of 1.5% of net collections recovered with no upfront fees, indicating a pivot within roughly seven months.

Timeline

2026-07-26MedCity News names AKASA, RapidClaims, Nym Health as active AI-RCM peers alongside Candid Health
2026-07-22Candid Health raises $120M Series D led by Sixth Street Growth, tripling 2025 valuation
2026-06-30LunaBill's site shows shift to 1.5%-of-net-collections outcomes pricing, no upfront fees
2026-02-03Infinitus Systems launches Agentic AI Member Services Suite for payors
2026-01-31LunaBill YC page reports $764K contracted ARR, $428K live revenue
2025-11-18LunaBill closes seed round (~$3.5M) from Y Combinator and Pioneer Fund
2025-11-11LunaBill publishes Launch YC post citing 1.2M+ transcripts, 100 concurrent calls per client
2025-07-01LunaBill launches as part of YC Fall 2025 (F25) batch

Revision history

27 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

Nexus Terrain Metorial